A patient who has had an MI is taking a beta blocker. What is the main benefit of beta blocker therapy for this patient?

Choice A rationale Beta-blockers, such as propranolol, are not known to cause vasodilation of the coronary arteries. These medications block the effects of epinephrine, which results in a reduction in heart rate and blood pressure, but they do not directly dilate the coronary arteries. The main effect is on cardiac workload and oxygen demand. Choice B rationale Beta-blockers primarily function by antagonizing the effects of catecholamines on beta-adrenergic receptors, leading to a decrease in the force of cardiac contraction (negative inotropic effect). This reduction in contractility lowers the heart's workload and oxygen demand, which is beneficial in post-MI patients, not by increasing it. Choice C rationale Beta-blockers produce a negative chronotropic effect by blocking beta-1 receptors in the sinoatrial (SA) node. This action slows the heart rate, allowing for increased diastolic filling time and improved coronary artery perfusion. This decreased heart rate also reduces myocardial oxygen consumption, which is crucial after a myocardial infarction. Choice D rationale By reducing heart rate, contractility, and blood pressure, beta-blockers significantly decrease the oxygen demand of the heart muscle. This is their primary therapeutic benefit following an MI. A lower myocardial oxygen demand helps to prevent further ischemia and limits the extent of myocardial damage.